Prof. HATİCE NUR OLGUN


Onkoloji Enstitüsü,


Research Areas: Health Sciences


Names in Publications: H. N. Olgun, N Olgun, Nur Olgun, Hatice Nur Olgun, Olgun, H.N., Olgun, N, Olgun Hatice Nur

Metrics

Publication

473

Citation (WoS)

896

H-Index (WoS)

18

Citation (Scopus)

997

H-Index (Scopus)

18

Project

48

Thesis Advisory

16

Open Access

35
UN Sustainable Development Goals

Education Information

1980 - 1984

1980 - 1984

Expertise In Medicine

Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey

1973 - 1979

1973 - 1979

Undergraduate

Ege University, Faculty Of Medicine, Turkey

Research Areas

Health Sciences

Academic Titles / Tasks

1985 - Continues

1985 - Continues

Professor

Dokuz Eylul University, Onkoloji Enstitüsü

Managerial Experience

2012 - Continues

2012 - Continues

Director of The Institution

Dokuz Eylul University

Advising Theses

2021

2021

Doctorate

Medulloblastomda moleküler belirteçler ve klinik ilişkisi

OLGUN H. N. (Advisor)

E.ATASEVEN(Student)

2020

2020

Doctorate

Kanserde Heterojenitenin Klinik Önemi

OLGUN H. N. (Advisor)

T.ÇAĞRI(Student) Sustainable Development

2020

2020

Doctorate

Nöroblastom ve Hippo Sinyal Yolağı

ALTUN Z. S. (Co-Advisor), OLGUN H. N. (Co-Advisor)

S.KUM(Student)

2015

2015

Doctorate

Relationship between neuroblastoma and microRNA

OLGUN H. N. (Advisor)

K.ERGİN(Student) Creative Commons License

2013

2013

Post Doctorate of Medicine

The time to diagnosis in childhood lymphomas and malignant solid tumors

OLGUN H. N. (Advisor)

R.EMRE(Student) Creative Commons License

2012

2012

or carboplatin during treatment

OLGUN H. N. (Advisor)

D.İNCE(Student) Creative Commons License

Published journal articles indexed by SCI, SSCI, and AHCI

2009

2009

Reply

Güneş D., Olgun N.

Turkish Journal of Pediatrics , vol.51, no.4, pp.405-406, 2009 (SCI-Expanded) identifier identifier

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

2023

2023

G6PD AS A PROGNOSTIC BIOMAKER IN NEUROBLASTOMA BY BIOINFORMATIC ANALYSIS

Yuan H., Altun Z. S., Kum Özşengezer S., Olgun H. N.

VIII. Türkiye in vitro Diyagnostik (IVD) Sempozyumu “PREKLİNİK MODELLEMELER” , İzmir, Turkey, 29 November - 01 December 2023, vol.1, no.1, pp.3-4 Sustainable Development

2023

2023

PD1, PDL1 POZITIFLIĞI SAPTANAN REFRAKTER LENFOMA OLGULARINDA NIVOLUMAB DENEYIMIMIZ

Laleoğlu P., Kızmazoğlu D., Hamiş B., İnce D., Çeçen R. E., Tüfekçi Ö., et al.

22.Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, vol.044, pp.176 Sustainable Development

2023

2023

TREATMENT EXPERIENCE OF CHILDHOOD HEAD AND NECK HEMANGIOMAS

Kızmazoğlu D., Olgun H. N.

IFOS, Dubai, United Arab Emirates, 17 - 21 January 2023, pp.1-2

2022

2022

Evaluation of Yap-1 in Risk Classes and Prognosis in Neuroblastoma

Kum Özşengezer S., Aktaş S., Altun Z. S., Sanlav G., Baran B., Kızmazoğlu D., et al.

Dokuz Eylul University INTERNATIONAL SYMPOSIUM SERIES ON GRADUATE RESEARCHES 2022, İzmir, Turkey, 4 - 05 November 2022, pp.20 Sustainable Development

2022

2022

EFFECT OF METFORMIN AND CISPLATIN COMBINATION THERAPY ON IN VITRO HYPOXIC NEUROBLASTOMA MODEL

Bayrak Ö., Bayrak S., Olgun H. N., Başbınar Y.

10. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 16 - 18 December 2022, pp.18-19 Sustainable Development

2022

2022

Pediatrik Nadir Tümörlerde Yeni Nesil Dizileme ile Pankanser Panelin Rolü

Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Olgun H. N.

EurasianBioChem 2022 5th international eurasian conference on biological and chemical sciences, Ankara, Turkey, 23 - 25 November 2022, pp.1262 Sustainable Development

2022

2022

INTEGRATIVE ANALYSIS OF FEN1 EXPRESSION AND PROGNOSTIC IMPACT IN NEUROBLASTOMA

Yuan H., Altun Z. S., Olgun H. N.

The 54th Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, vol.69, no.29952, pp.225 Creative Commons License Sustainable Development

2022

2022

WILMS TUMOR: SINGLE CENTER EXPERİENCE

Çeçen R. E., Kızmazoğlu D., Karataş E., Coşkuner D., Umay C., Ulusoy O., et al.

The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1686

2022

2022

LYMPHOMA AND SOLID TUMORS AMONG ADOLESCENTS 15-19 YEARS OF AGE: SINGLE CENTER EXPERIENCE

Kızmazoğlu D., Çeçen R. E., İnce D., Olgun H. N.

The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1566 Sustainable Development

2022

2022

Incidence, risk factors and outcome of thrombotic events in pediatric cancer patients

Çeçen R. E., Kızmazoğlu D., Tüfekçi Ö., Yılmaz Ş., İnce D., Olgun H. N., et al.

XXX. Congress of the International Society on Thrombosis and Haemostasis 2022 , London, England, 9 - 13 July 2022, pp.499 Creative Commons License Sustainable Development

2022

2022

25 YEARS OF LANGERHANS CELL HISTIOCYTOSIS EXPERIENCE OF A SINGLE CENTER

İnce D., Kızmazoğlu D., Çeçen R. E., Güleryüz Uçar H., Özer E., Olgun H. N.

The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1859

2022

2022

DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS

Olgun H. N., Çeçen R. E., İnce D., Kızmazoğlu D., Baysal B., Önal A., et al.

The 54th Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, vol.167, no.1786, pp.225 Sustainable Development

2022

2022

PRECISION MEDICINE IN NEUROBLASTOMA: EXPERIENCE WITH NEXT GENERATION SEQUENCING

Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Gökbayrak Ö., Çeçen R. E., İnce D., et al.

1st International Basic Oncology Congress. , İstanbul, Turkey, 2 - 04 June 2022, vol.5, no.1134059, pp.40 Creative Commons License Sustainable Development

2022

2022

INVESTIGATION OF THE POTENTIAL EFFECTS OF YAP-1 AND NESTIN ON RISK CLASSES AND PROGNOSIS IN NEUROBLASTOMA

Kum Özşengezer S., Baran B., Kızmazoğlu D., Sanlav G., Aktaş S., Aktaş T., et al.

1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1136813, pp.60 Creative Commons License Sustainable Development

2022

2022

Analysis of Tribbles Homolog 3 (TRIB3) Expression Levels in Neuroblastoma: Preliminary study

Baran B., Sanlav G., Kızmazoğlu D., Kum Özşengezer S., Altun Z. S., Aktaş S., et al.

1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1137378, pp.56 Creative Commons License Sustainable Development

2022

2022

S-100 Protein Expression Levels as a Potential Prognostic Marker in Neuroblastoma

Sanlav G., Baran B., Kızmazoğlu D., Kum Özşengezer S., Aktaş S., Altun Z. S., et al.

1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1136890, pp.55 Creative Commons License Sustainable Development

2022

2022

Heterogenetiy for Immune and Inflamatuar Response in Neruoblastoma

Aktaş T., Kızmazoğlu D., Aktaş S., Serinan E., Çeçen R. E., İnce D., et al.

VII. Türkiye in vitro Diyagnostik Sempozyumu, İzmir, Turkey, 27 - 29 April 2022, pp.10 Sustainable Development

2022

2022

The effect of SMAC mimetic on apoptotic gene expressions

Baran B., Altun Z. S., Yuan H., Aktaş S., Olgun H. N.

4th Congress of Cell Death Research Society-Turkiye with International Participation, İzmir, Turkey, 17 - 19 March 2022, vol.1, no.24, pp.81-82 Sustainable Development

2021

2021

Stemness Related Genes Cause Resistance to SMAC mimetics in Neuroblastoma Cells.

Baran B., Altun Z. S., Holyavkin C., Olgun H. N.

EACR-AstraZeneca Virtual Conference ‘Drug Tolerant Persister Cells, London, United Kingdom, 07 December 2021, pp.8

2021

2021

Effect of MSCs on Cisplatin Toxicity in Neuroblastoma Model

AKTAŞ S., EVİN ESKİCİOĞLU H., ERÇETİN A. P., Aktaş T., YILMAZ O., KIRKIM G., et al.

3. International Baku Scientific Research Congress The Book of Full Text, Baku, Azerbaijan, 13 July 2021, pp.801-816

2021

2021

Nöroblastomda Anti-Tümör Ajanı Olarak SMAC Mimetiklerin Kullanımı

Altun Z. S., Baran B., Olgun H. N., Aktaş S.

9. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 12 - 13 November 2021, pp.12-13

2021

2021

Treatment of Relapse/ Refractory Neuroblastoma: Dokuz Eylul Experience

Çeçen R. E., İnce D., Kızmazoğlu D., Akyol Ş., Özdoğan Ö., Özer E., et al.

Virtual 53rd Congress of the International Society of Paediatric Oncology, 21 - 24 October 2021, vol.68, no.5, pp.215-216

2021

2021

CAULERPIN FROM CAULERPA CYLINDRACEA INHIBITS CELL PROLIFERATION, MIGRATION AND INVASION IN HCT-116 HUMAN COLORECTAL CANCER CELL LINE

Mert Ozupek N., Cavaş L., Olgun H. N., Ellidokuz H., Başbınar Y.

3rd International Cancer and Ion Channels Congress (CANCERION-2021), İstanbul, Turkey, 16 - 18 September 2021, pp.57 Sustainable Development

2021

2021

The Effects of CDDP and OLE in Neuroblastoma

Dursun D., Altun Z. S., Tütüncü M., Serinan E., Aktaş S., Olgun H. N.

Covid-19 Pandemisinde Araştırma-Yayın ve Eğitim Süreçlerine Bakış Kongresi, İzmir, Turkey, 15 - 16 January 2021, pp.24

2020

2020

Audiological evaluation of the effect of Darbepoetin on the prevention of cisplatin ototoxicity

BAYRAK F., OLGUN Y., ESKİCİOĞLU E., SERİNAN E., KOLATAN H. E., ÇETİNAYAK H. O., et al.

2nd Interational Medical Congress Of Izmir Democracy University- Healty Aging and Aging ’xxasssoicated Diseases , online, 17 - 19 December 2020

2020

2020

The investigation of protective role of Acetyl L-Carnitine on cisplatin myelosuppression in experimental animal models

KIZMAZOĞLU D., İNCE D., AKTAŞ S., ALTUN Z. S., KOLATAN H. E., YILMAZ O., et al.

2nd International Medical Congress of Izmir Democracy University, Healty Aging anbd Aging-Associated Diseases, IMCUDU 2020, online izmir, 17 - 19 December 2020, pp.175-177

2020

2020

Investıgatıon Of The Effects Of Cısplatın And Paclıtaxel On Stem Cell Markers And Cell Death Mechanısms In Ovarıan Cancer

KUM ÖZŞENGEZER S., ÇUMRALI S., ALTUN Z. S., OLGUN H. N.

2nd International Medical Congress of Izmir Democracy University, Healty Aging anbd Aging-Associated Diseases, İzmir online, Turkey, 17 - 19 December 2020, pp.530-534 Sustainable Development

2020

2020

THE EFFECT OF FUCOİDAN AND CISPLATIN ON DNA DAMAGE RELATED GENES IN COCHLEAR CELLS

Tütüncü M., Kum Ozsengezer S., Olgun Y., Altun Z. S., Olgun H. N.

52nd congress of the International Society of Paediatric Oncology (SIOP), Ottawa, Canada, 14 - 17 October 2020, pp.1

2019

2019

Single Center Experience of Non-Rhabdomyosarcoma Soft Tissue Tumors

İnce D., Akyol Ş., Kızmazoğlu D., Baysal B., Olguner M., Demiral A. N., et al.

51st Congress of the International Society of Paediatric Oncology, Hawaii, United States Of America, 23 - 26 October 2019

2019

2019

The Effect of Oleuropein against cisplatin-induced ototoxicity by inducing DNA-damage related genes

Olgun Y., Tütüncü M., Kum Özşengezer S., Güneri E. A., Aktaş S., Altun Z. S., et al.

12th APSCI (Asia Pacific Symposium on Cochlear Implants) and Related Sciences 2019, Tokyo, Japan, 27 - 30 November 2019

2019

2019

Juvenile Xanthogranuloma:A Single Center Experience

İNCE D., BAYSAL B., KIZMAZOĞLU D., ÖZER E., OLGUN H. N.

51st Congress of the International Society of Paediatric oncology, Lyon, France, 23 - 26 October 2019

2019

2019

Sesquiterpene lactones as a candidate anti-cancer agent in childhood cancer

EROL A., AKTAŞ S., Gökbayrak Ö., KAYALAR H., OLGUN H. N.

Cancer Treatment Breast Cancer and Biomarkers, Paris, France, 20 - 21 March 2019, vol.11 Sustainable Development

2019

2019

The effect of normoxic/hypoxic microenvironment on hypoxia-inducible factor 1 mechanism in neuroblastoma

TOKSÖZ F., SEVER T., İNANÇ SÜRER Ş., MEÇO H. E., KURTER H., ÇALIBAŞI KOÇAL G., et al.

International Hippocrates Congress on Medical and Health Sciences, Ankara, Turkey, 1 - 03 March 2019, pp.101-111

2018

2018

Artificial intelligence methods for risk assessment of neuroblastoma

Leblebici A., Uncu B., Onan A., Baskın Y., Olgun H. N.

50th Congress of the International Society of Paediatric Oncology (SIOP 2018), Kyoto, Japan, 16 - 19 November 2018, pp.5-6

2018

2018

A 3year review of a cohort Turkish Paediatric Oncology Group (TURKPEDPGx)

Başbınar Y., Uncu B., Leblebici A., Çalıbaşı Koçal G., Çıtak Ç., Ak E., et al.

50th Congress of the International Society of Paediatric Oncology (SIOP), Aomori, Japan, 9 - 11 November 2018, pp.1

2018

2018

PO-392 Mesenchimal Stem Cell and Cisplatin Interference in Neuroblastoma Experimental Animal Model

AKTAŞ S., ERÇETİN A. P., AYDIN M., ÇALİŞİR M., BEKÇİOĞLU Ö., YILMAZ O., et al.

50th Congress of the International Society of Pediatric Oncolog, Kyoto, Japan, 14 - 16 November 2018

2018

2018

Comparative Genomic Hybridisation in Neuroblastoma: A molecular Approve for Tumor Heterogeneity

Aktaş T., AKTAŞ S., BARAN B., TOSUN H., DİNİZ G., ÇAKIR Y., et al.

7.ci Multidisipliner Kanser Araştırma ve 1.ci Temel Onkoloji Kongresi, 11 - 14 October 2018, pp.129-130

2018

2018

Isolated central nervous system Non-Hodgin lymphoma

ERDEM M., KIZMAZOĞLU D., ATLAN M. A., YILDIRIM E., ÇETİNAYAK H. O., İNCE D., et al.

6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, pp.108

2018

2018

Isolated central nervous system Non-Hodgkin lymphoma

Erdem M., Kizmazoglu D., Atlan M. A., Yildirim E., ÇETİNAYAK H. O., İNCE D., et al.

6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, vol.182, pp.108 identifier

2018

2018

A single center experience of pediatric Hodgkin lymphoma

Ince D., Erdem M., Kizmazoglu D., Cecen E., Demiral A. N., Cetingoz R., et al.

6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, vol.182, pp.102 identifier

2018

2018

Evaluation of ototoxicity in children with head and neck cancer who received cisplatin and /or carboplatin therapy

OLGUN Y., İNCE D., KIZMAZOĞLU D., ERDEM M., KIRKIM G., DEMİRAL A. N., et al.

15TH INTERNATIONAL CONFERENCE ON COCHLEAR IMPLANTS AND OTHER IMPLANTABLE AUDITORY TECHNOLOGY, 27 - 30 June 2018 Sustainable Development

2018

2018

Paediatric sinonasal malignant masses and the mimickers

Cekdemir Y. E., Salman M., SARIOĞLU F. C., GÜLERYÜZ H., Kızmazoglu D., BAYSAL B., et al.

The 54th Annual Meeting 40th Post Graduate Course of the European Society of Paediatric Radiology (ESPR), Berlin, Germany, 18 - 22 June 2018

2018

2018

Ewing sarcoma family of tumours: Beyond the bone!

SARIOĞLU F. C., Salman M., Cekdemir Y. E., GÜLERYÜZ H., Kızmazoglu D., BAYSAL B., et al.

The 54th Annual Meeting 40th Post Graduate Course of the European Society of Paediatric Radiology (ESPR), 18 - 22 June 2018

2017

2017

is oluropein protective for cisplatin induced ototoxicity in HEI OC1 cells

AYDIN M., OLGUN Y., ALTUN Z. S., AKTAŞ S., OLGUN H. N.

11TH ASIA PACIFIC SYMPOSIUM ON COCHLEAR IMPLANTS AND RELATED SCIENCES, 19 September - 22 December 2017

2017

2017

Nötropenik Ateş Odağı: Listeria menenjiti

ERDEM M., KIZMAZOĞLU D., İNCE D., KALEMCİ O., BELET N., KÖROĞLU T., et al.

22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017

2017

2017

”İzoleSantral Sinir Sistemi Lenfoması”

ERDEM M., KIZMAZOĞLU D., ATTAN M., YILDIRIM E., ÇETİNAYAK H. O., İNCE D., et al.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017

2017

2017

Nöroblastomda kemoterapi

OLGUN H. N.

Pediatrik Solid tümörler kursu, İzmir, Turkey, 25 March 2017

2017

2017

Treatment of Relapse Neuroblastoma: Dokuz EylulUniversity Experience

İNCE D., ERDEM M., KIZMAZOĞLU D., ÖZER E., AKTAŞ S., GÜLERYÜZ H., et al.

49th Congress of the International Society of Paediatric Oncology, 12 - 15 October 2017, vol.64, pp.26772

2016

2016

Paediatric Hodgkin lymphoma A single center experience from the West Part of Turkey

MUTAFOĞLU K., İNCE D., OLGUN H. N., GÜLERYÜZ H., ÖZER E., erdem m., et al.

The 48th Annual Congress of the International Society of Paediatric Oncology, 19 - 22 October 2016

2016

2016

Wilms tumor A single center experience

İNCE D., MUTAFOĞLU K., KIZMAZOĞLU D., DEMİRAL A. N., ÖZER E., aktürk n., et al.

The 48th Annual Congress of the International Society of Paediatric Oncology, 19 - 22 October 2016

2016

2016

Can High Risk Group Be Categorized As High Risk And Ultra High Risk In Neuroblastoma

Demir A. B., Aktaş S., Altun Z. S., Erçetin A. P., Olgun H. N.

48th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201

2016

2016

Assessment of the Clinical Importance of Molecular Basis of Neuroblastoma A Proteomic Approach

Demir A. B., Altun Z. S., Aktaş S., Olgun H. N.

48th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201

2016

2016

In vitro Effect of Borate Derivatives on Neuroblastoma Cells

ERÇETİN A. P., AKTAŞ S., AYDIN M., SOMEN M., PAŞAYİĞİT M., OLGUN H. N., et al.

6.Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.190

2016

2016

In vitro Effect of Flubendazole on Neuroblastoma Stem Cells

ERÇETİN A. P., AKTAŞ S., GENÇ N., SERİNAN E., ALTUN Z. S., OLGUN H. N.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.125

2016

2016